Open main menu
Search Ctrl + K
Free Trial
Loading...
Bellerophon Therapeutics, Inc.
Watch
Pharmaceutical Preparations
NASDAQ.BLPH
184 Liberty Corner Road, Suite 302, Warren, NJ, 07059
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Latest Filings – Non-Ownership
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers, Submission Of Matters To A Vote Of Security Holders, Financial Statements And Exhibits
04 Mar 24
SCHEDULE 13G
01 Mar 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
12 Feb 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
12 Feb 24
8-K
Entry Into A Material Definitive Agreement, Unregistered Sales Of Equity Securities, Material Modifications To Rights Of Security Holders, Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year, Other Events, Financial Statements And Exhibits
30 Jan 24
SCHEDULE 13G
26 Jan 24
8-K
Submission Of Matters To A Vote Of Security Holders, Other Events
22 Jan 24
8-K
Submission Of Matters To A Vote Of Security Holders, Other Events
10 Jan 24
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
03 Jan 24
25-NSE
Notification Filed By National Securities Exchanges Of The Removal From Listing And Registration Of Matured, Redeemed Or Retired Securities.
27 Dec 23
8-K
Submission Of Matters To A Vote Of Security Holders, Other Events
12 Dec 23
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers
21 Nov 23
10-Q
Quarterly Filing
14 Nov 23
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
06 Nov 23
PRE 14A
Preliminary Proxy Statement Not Yet Definitive.
27 Oct 23
RW
Registration Withdrawal Request.
16 Oct 23
S-8 POS
Post-effective Amendment To An S-8 Filing.
16 Oct 23
S-8 POS
Post-effective Amendment To An S-8 Filing.
16 Oct 23
S-8 POS
Post-effective Amendment To An S-8 Filing.
16 Oct 23
S-8 POS
Post-effective Amendment To An S-8 Filing.
16 Oct 23
Latest Filings – Ownership
SC 13G/A
14 Feb 24
SC 13G
26 Jan 24
SC 13D/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
18 Oct 23
SC 13D/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
17 Oct 23
4
Puissance Capital Management Lp
16 Oct 23
4
Cloyd Mary Ann
09 Jun 23
4
Dekker Martin
09 Jun 23
4
Fernandes Peter
09 Jun 23
4
Amin Naseem
09 Jun 23
SC 13G/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
09 Jun 23
4
Kim Bobae
09 Jun 23
4
Teufel Crispin
09 Jun 23
4
Bruder Scott P
09 Jun 23
4
Shah Parag Suresh
09 Jun 23
4
Wang Theodore T
09 Jun 23
SC 13D/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
08 Jun 23
144
Puissance Life Science Opportunities Fund Vi
07 Jun 23
4
Puissance Life Science Opportunities Fund Vi
07 Jun 23
SC 13G/A
Amended Statement Of Beneficial Ownership Of More Than 5%.
26 May 23
SC 13G
25 May 23